Price capping takes sheen off condom sales following government decision

Thursday, April 30, 2015

It’s the condom makers turn to seek protection as sales of the male contraceptive have plunged drastically following a government decision to dub it an essential drug and cap its price more than a year ago. The contraceptive segment was growing at double digits until the government in November 2013 included condoms in the list of essential medicines and fixed their ceiling price in the Drug Pricing ControlOrder (DPCO).

As a result, from around 15% expansion then, it has consistently slowed each quarter and has now hit a negative growth number, a first for the segment. Generally, if products become cheaper, they should sell more. But not for the range of dotted, ribbed, flavoured and even glowing contraceptives that were promoted as away of spicingup users’ lives, said companies.

Source: The Economic Times (link opens in a new window)

Health Care
reproductive health